|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Profit (loss) before income taxes | |||||
| Adjustments to reconcile profit before tax to net cash flows : | |||||
| Amortization and impairment of property, plant and equipment | |||||
| Amortization and impairment of intangible assets | |||||
| Impairment of digital assets | |||||
| Share-based payment expense | |||||
| Increase (Decrease) in provisions | |||||
| Interest expense, net | |||||
| Impact of debt reimbursement | |||||
| Loss (gain) on debt extinguishment, net of non-cash transaction cots | |||||
| Foreign exchange loss (gain) | |||||
| Bad debt expense | |||||
| Loss (gain) on disposal of assets | |||||
| Loss on sale of digital assets | |||||
| Working capital adjustments: | |||||
| Decrease (Increase) in trade receivables and other receivables | |||||
| Decrease (Increase) in inventories | |||||
| Increase in research tax credit receivable | |||||
| Increase (Decrease) in trade payables and other liabilities | |||||
| Increase (Decrease) in contract liabilities | |||||
| Increase (Decrease) in government grant advances | |||||
| Income tax paid | |||||
| Net cash flow used in operating activities | |||||
| Investing activities: | |||||
| Purchase of intangible assets and property, plant and equipment | |||||
| Purchase of digital assets | |||||
| Capitalized development expenditures | |||||
| Sale (Purchase) of financial assets | |||||
| Decrease (Increase) of short-term deposit | |||||
| Interest received | |||||
| Investment in ACP Advanced Circuit Pursuit, net of cash acquired | |||||
| Proceeds from sale of digital assets | |||||
| Proceeds from sale of 4G intangible and tangible assets | |||||
| Net cash flow from (used in) investments activities | |||||
| Financing activities: | |||||
| Private equity offering proceeds, including pre-funded warrants, net of transaction costs paid | |||||
| Proceeds from issue of warrants and exercise of stock options/warrants granted under share-based payment plans, net of transaction costs | |||||
| Proceeds from convertible debt, net of transaction costs paid | |||||
| Proceeds from exercise of pre-funded and 2025 warrants | |||||
| Proceeds (repayment of) from interest-bearing receivables financing, net | |||||
| Proceeds from interest-bearing research project financing | |||||
| Proceeds from related party loans | |||||
| Purchase of treasury shares | |||||
| Repayment of loans | |||||
| Repayment of government loans | |||||
| Repayment of convertible debt | |||||
| Repayment of interest-bearing research project financing | |||||
| Payment of lease liabilities | |||||
| Interest paid | |||||
| Net cash flows from (used in) financing activities | |||||
| Net increase in cash and cash equivalents | |||||
| Net foreign exchange difference | |||||
| Cash and cash equivalents at January 1 | |||||
| Cash and cash equivalents at period end | |||||
Loading...
